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Abstract
Background: Solitary bone cysts (SBC) are benign, tumor-like lesions, which most frequently occur in the proximal
metaphyseal-diaphyseal region of the humerus and femur of children and adolescents. The lack of a clear
pathoetiology has impeded the development of treatment strategies. Up to date there is no consensus or official
guideline for when and how treat SBC. The purpose of this study was to evaluate the effectiveness and the
longterm clinical outcome of the treatment of SBC. Different techniques have been used dependant of the site of
lesion, dimension, medical history and activity status.
Methods: 135 skeletal immature patients with a solitary bone cyst were included. A follow up of 36 months or
more was available for all patients. 22 patients were treated conservatively. All the other patients had at least one
surgical intervention. The following four surgical treatment modalities were used: injection of methylprednisolon
acetat (steroids), intramedullary nailing (IN), IN + steroids and curettage plus bone grafting.
Results: There was no significant difference between the treatment groups with respect to secondary fractures,
function, pain, or complications. In the individual groups the failure rate after initial treatment was 36,6 % with
steroids, 50 % with intramedullary nailing, 21,4 % with intramedullary nailing plus steroids and none in the
remaining group.
Conclusion: Steroid injection remains a reliable method for treating solitary bone cysts owing to its low
invasiveness. To prevent fractures and allow a full weight bearing, internal fixation in combination with
methylprednisolon acetat injections seems to be the most favorable in weight bearing bones.
Background
Solitary bone cysts (SBC) also known as unicameral
bone cysts (UBC) are benign, fluid-filled, single cham-
bered tumor-like lesions. They most commonly occur in
the proximal metaphyseal-diaphyseal region of the
humerus and femur of children and adolescents. The
absolute incidence is unknown, it is estimated that
approximately 3 % of all bone tumors are SBC [1]. Since
SBC show specific radiographic features on plain x-ray
further imaging studies are usually not required, espe-
cially in long bones. The classic appearance is a centrally
located, radiolucent, well-marginated, slightly expansile
lesion of the proximal metaphysis. The growth plate is
normally not affected by these expansive cysts. The cor-
tex of the bone have a tendency to get thin and weak.
This thinned cortex is an area of structural weakness
and is prone for a pathological fracture. The ‘fallen leave’
sign is indicative for SBC [2]. The cyst is often asymp-
tomatic, but pain in the affected region may be present.
Often the first and only symptom is a pathological frac-
ture following a trivial trauma [2, 3], but sometimes the
initial diagnosis is made after a radiological investigation
performed for other reasons.
Since the first documentation of SBC by the German
pathologist Rudolph Virchow in 1876 [4], the cause re-
mains unspecified. Therefore the evolution of a conclu-
sive treatment targeting the source is still missing.
Numerous hypotheses have been proposed to explain
the pathogenesis of SBC, e.g. bone resorptive properties
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of the cyst lining, vascular obstruction, increase in intra-
cavitary osseous pressure,inflammation or traumatic
causes [5–10].
There is a wide selection of options to handle SBCs,
including observation, decompression of the cyst (using
cannulated screws or nails) instillation of bone marrow,
steroids or demineralized bone matrix, mechanical dis-
ruption of the cyst (usually by curettage), structural sup-
port (e.g. flexible intramedullary nails or bone grafting)
or combined approaches that address the lesion on mul-
tiple levels.
The objective of therapy is to prevent a pathologic
fracture or re-fracture, promote cyst healing, and to
avoid cyst recurrence. The purpose of this study was to
assess the healing rates of SBC after different therapy
modalities as well as the long term clinical outcome after
treatment.
Methods
The patient archive at Olgahospital Stuttgart was
searched to identify all skeletal immature patients
treated for SBC between 2000 and 2010. We found 164
patients (112 boys and 52 girls) who were diagnosed and
treated with a SBC. The inclusion criterions for this
study were: a solitary bone cyst (diagnosed by histo-
logical or radiological features) and follow up for at least
3 years or Neer classification I and skeletal maturity [2].
29 patients were excluded, because of insufficient long-
term clinical information (follow-up <3 years) or lost to
follow-up. 22 patients had been managed conservatively
(e.g. splint, cast), because the probability of healing was
considered very high (n = 18), or the consent for an op-
eration was denied. All the other patients (n = 113) had
at least one kind of surgical intervention. The patient
demographics are shown in Table 1.
Surgery
All procedures were performed under general anaesthe-
sia. Surgical procedures were the following:
 aspiration and injection with methylprednisolone
(group I),
 elastic stable intramedullary nailing (group II),
 a combination of the above (group III),
 curettage followed by bone grafting with an
autograft or allograft (group IV).
Steroid injection
We used the technique of Scaglietti [9]. in a modified
manner. A 11-gauge aspiration needle was inserted per-
cutaneously to aspirate the contents of the cyst. 80 to
160 mg of methylprednisolone-acetat was inserted into
the cyst. The dose of steroid ranged depending on cyst
size. The patient was discharged on the same day, after
the injection,. This procedure was performed three times
with an interval of four to six weeks between every in-
jection. Pathological fractures were allowed to heal for
six weeks before the treatment with steroids was started.
All patients treated with steroids as a primary interven-
tion received exactly 3 injections.
Intramedullary nailing
For intramedullary nailing we followed the classical sur-
gical technique, as reported by Ligier et al. [11] using a
retrograde nailing approach. In case of a pathological
fracture, first the closed reduction of the fracture was
performed. Under fluoroscopic guidance the elastic
intramedullary nailing (in an ascending manner) was
completed. The diameter of the nails (2.0 to 3.0 mm)
was selected on the basis of the anterior-posterior radio-
graph and intraoperative findings according to the prin-
ciples described earlier [11]. Same setup was used in the
case of prophylactic intramedullary nailing.
Curettage
Utilizing a standard approach to the different locations of
the cyst, the cortex above the lesion was opened by four
to six drill holes thru the cortex and using a chisel to con-
nect the holes and remove the bony window. After the
fluid was removed, the membrane of the cyst was rigorous
curetted. To monitor the procedure the fluoroscope was
used to assure that the curettage reached the outside of
the SBC.
Bone graft
For bone grafting either autologous bone from the iliac
crest or allogenic bone (Phoenix®, TBF, France) was used
and the complete cyst was packed.
Table 1 Patient demographics and Site of the lesion
Mean age in years 9,6 (4,2 – 16,4)
Male/female 87/48
Active cyst 74 55 %
Fracture before initial treatment 93 69 %
Humerus 59 44 %
Femur 49 36 %
Tibia 7 5,2 %
Fibula 5 3,7 %
Radius 2 1,5 %
Calcanues 8 5,9 %
Os pubis 3 2,2 %
Os ilium 2 1,5 %
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Postoperative treatment and radiological control
Postoperative treatment was aligned to the specific find-
ings of the lesion. The therapy varied upon the site and
location, size and volume, presence of fracture and dis-
placement etc. Thus treatment (not only postoperative)
ranged from simple dressings and splints to cast therapy
and activity and weight bearing restrictions.
Radiographs were taken six and 12 weeks after surgery
and from then on every six months. Controlled by im-
provement or recurrence the radiological monitoring
was individually modified. All radiographs taken during
the course of treatment were analyzed and the cyst vol-
ume was calculated (length by width by depth in cubic
centimeters based on two orthogonal plain radiographs).
SBCs are classified into active or latent according to Jaffe
and Lichtenstein [7]. When the distance to the physis
was less than 10 mm the cyst was classified as an active
cyst. All cyst showing more tan 10 mm distance from
the physis were classified as latent.
Measuring the volume of the cyst is an attempt to
quantify the SBC, but normally the volume is not
matched to the size of the bone. One option is to match
the volume to the diameter of the (normal part of the)
shaft as it was proposed by Kaelin and MacEwen as “cyst
index” [12].
The Neer/Cole rating system [2, 13] was used to moni-
tor treatment response. The radiographic results were
defined as I (healed) when complete obliteration of the
cyst was shown. Grade II (residual defects) was defined
new bone filled the lesion, but some opaque areas were
still present. Grade III (cyst visible) was defined when
multilocular and lucent residue areas were visible. Grade
IV (cyst clearly visible) was assigned when the cyst was
unchanged after the treatment. Grades I and II were
considered as good results: cyst healed; grades III and IV
were considered poor results: cyst not healed or pending
pathological fracture.
The primary study outcome was the cyst-healing and
the secondary outcome included the function and activ-
ity, pain, subsequent fractures, and complications. Pain
that persisted at least 1 year after surgery was scored as
a binary variable (present or absent). Physical activity
was scored on a five-level response scale (1 not re-
stricted in daily activity/playing – 5 substantial limited
in daily activity/playing).
Do determine factors influencing the healing rate, the
following parameters were included into the analysis:
Sex, Age, Site, Cyst volume, Cyst status, Cyst index
and Fracture before initial treatment.
Statistical analysis
Analysis was conducted using SPSS software (version 15,
SPSS Inc., Chicago, IL, USA). For the analysis of dichot-
omous variables between two groups, a chi-square cross
tab test was performed. Values of p < 0.05 were consid-
ered significant. Recurrence rate was determined using
the Kaplan-Meier method with treatments compared by
the log rank test.
Results
In 83 of 135 patients the diagnosis of SBC was con-
firmed by the pathologist. Since no material for histo-
logical examination was obtained in the 52 remaining
patients the diagnosis based on the typical radiographic
morphology. At presentation, 93 patients (68.9 %) had a
pre-existing pathological fracture. In our patients patho-
logical fractures significantly involved the humerus more
often than the femur (p = 0.039). There was an equal dis-
tribution of fractures in both sex. 39 patients (28.9 %)
complained of pain at the site of the lesion and in 3 pa-
tients the SBC was recognized accidentally, because an
x-ray was done for other reasons.
The median follow-up time period for all patients was
57.2 (36 – 92) month. The cysts were mainly located in
long bones (n = 122), most commonly in the humerus
(n =59) and the femur (n = 49). The other locations in
long bones were the tibia (n = 7), fibula (n = 5) and ra-
dius (n = 2). Nearly 90 % (109 of 122) of the lesions were
located in the proximal part of the bone. Eight cysts
were located in the calcaneus, three in the os pubis and
two in the ilium.
The cyst volume found to be related to healing rate. If
the cyst volume was > 84.3 cm3 the healing rate for the
SBC was significantly reduced in comparison of all the
groups (p < 0.03). Considered the individual group, there
was no significant difference regarding the cysts size and
the healing rate allocable. Size and pathological fracture
was only dependent in long bones. From a size of
96.4 cm3, the probability of a pathological fracture was
significantly increased (p < 0047). The volume tends to
be bigger in the upper extremity compared to the lower
extremity, but did not reached significance in our
patients.
The cyst index at diagnosis showed a significant rela-
tion to the healing rate. The cyst index was similar in all
different groups but showed differences among the loca-
tions (upper extremity average 5.6 (SD 1.8) and lower
extremity average 4.8 (SD 1.3)). When the cyst index
was correlated with the healing rate the reference values
suggested by Kaelin [12] were used. In the upper and
lower extremity a cyst index < 3.5 showed a significant
lower failure rate than a cyst index > 5 - independent
from the treatment groups.
Of the 135 patients, 74 had an active bone cyst at an
age of 8.3 years and the other 61 had latent bone cysts
at an age of 11.8 years. Patients with active cysts were
significantly younger (p = < 0.01). In active cysts of long
bones we recognized a higher failure rate. This was not
Traub et al. BMC Musculoskeletal Disorders  (2016) 17:162 Page 3 of 7
significant between the different groups, nor the location
in the upper or lower extremity. A list of a parameters
included into the analysis is shown in Table 2.
The failure rate in the conservative group was 27.3 %
(6 of 22). Overall recurrence rate after primary surgical
therapy was 26.1 % (31/119) for all surgical procedures -
recurrence being defined as requiring further surgical
treatment (re-fracture, grade III/IV, limited function or
ongoing pain). 19 patients from the conservative group
(n = 5) and group I (n = 14) experienced a fracture after
initial treatment. There were no significant associations
between fractures and cyst activity, cyst area, loculation,
location in the upper or lower extremity, or location
within the bone. In the individual groups the failure rate
after initial treatment was 36.6 % (15 of 41) with ste-
roids, 50 % (4 of 8) with intramedullary nailing, 21.4 %
(12 of 56) in the intramedullary nailing plus steroids and
none in the curettage and bone graft group (see Table 3).
The Kaplan-Meier analysis shows that further surgical
treatment was required between 10–20 months after ini-
tial treatment (Fig. 1). Steroids and conservative treat-
ment were associated with earlier failures than the other
therapies. The failure rate was significantly higher in pa-
tients with an active bone cyst, independent from treat-
ment and location (p < 0.03).
After the surgery occasional pain, numbness, or tin-
gling was reported on the first visits (up to 6 month after
last treatment), there was not significantly different
among all the groups. Regarding the function there was
also no difference between the treatment groups. Func-
tion was persistently very good in all the patients (not
restricted in daily activity). We did not see a cyst recur-
rence after the cyst was completely healed (Neer Grade
I). At the time the patient reached skeletal maturity the
majority of the SBC were healed completely, only 22 %
of the SBC were classified Grade II. Not one of the pa-
tients reached skeletal maturity with a cyst graded III or
IV.
The first treatment choice was not successful in 37 pa-
tients, and all patients underwent an invasive interven-
tion. Three out of the 37 patients needed a third
operation. Five patients received a second course of ster-
oid injection (3× injections). One out of these five
needed a third intervention. In nine patients the IN had
to be change, because the nails did not bridge the cyst.
These cysts healed without any further treatment. 17 pa-
tients were retreated with intramedullary nailing plus
steroids, in two patients the cyst failed to heal after this
retreatment. In six patients a curettage and bone grafting
was performed as second line treatment, all of them
healed completely. In all patient (n = 3) where the sec-
ond line treatment failed, a curettage with bone graft
was performed.
Seven patients developed complications after invasive
treatment; one patient was treated for a donor-site infec-
tion after autologous bone grafting. Three patients had a
growth disturbance with a mild deformity of the shaft,
and two patients showed a limb shortening with epi-
physeal arrest. In one patient a femoral head necrosis
was observed - in this boy the cyst did not respond to
the steroid injection and no response was noted after
intramedullary nailing, thus a curettage and bone graft-
ing was performed. This is the only patient were the
function was not restored completely 2.5 years after the
last treatment. He still has some limitation walking long
distances and running or jumping.
Discussion
Whenever a child with a SBC is presented to a ortho-
pedic surgeon the decision whether to observe or treat
has to be made. There is no consensus or official guide-
line for when to treat a SBCs. If the decision is made to
treat the child with a SBC the demanding questions is,
how to treat. Currently, there is also no covenant on a
reliable exemplary therapy. Up to date there is an only
one multi-center randomized trial published, comparing
Table 2 Location of the SBC in the different groups. The
number in brackets shows failure of first line treatment
Clinical factors No. No. of healing (%) p-value
Sex
Male 87 63 (72.4 %) n.s.
Female 48 35 (72.9 %)
Age
< 10 years 92 70 (76.1 %) n.s.
> 10 years 43 28 (65.1 %)
Site n.s.
Humerus 59 42 (71.2 %)
Femur 49 34 (69.4 %)
other long bones 14 10 (71.4 %)
others 13 12 (92.3 %)
Volume
< 84,3 cm3 50 42 (84 %) 0.0279
> 84,3 cm3 85 56 (65.9 %)
Cyst status
Active cyst 74 44 (59.5) 0.0214
Latent cyst 61 54 (88.2 %)
Cyst index (in long bones)
< 3.5 35 30 (85.7 %) 0.0119
> 5 43 25 (58.1 %)
Fracture
Yes 93 72 (77.4 %) n.s.
No 42 26 (61.9 %)
The data in boldface represents the Chi-square test and Fisher’s exact test
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intralesional steroid injection and bone marrow injection
[13]. The indications for an invasive treatment should
consider prevention of pathologic fracture, reduction
and stabilization of fractures, prevention of prolonged
activity restriction and the consolidation of the cyst. In
the literature some reliable methods to calculate the
fracture risk are reported [14, 15]. Thus our aim was to
share our therapy experience and help to identify reliable
treatment for SBC.
Like the most retrospective studies this study has
certain limitations, including inherent selection bias.
Indications and treatment selection were based on
clinical criteria and physician discretion rather than
objective criteria. However, we believe the high num-
ber of patients analyzed compensate for any such in-
consistencies. Nonetheless, our retrospective study of
135 patients with a SBC having an average follow-up
of ~5 years is one of the largest in the literature. In
our patients we had significantly more humerus than
femur fractures. This finding is in concordance with
previous studies [5, 16]. It is assumed that the lack of
weight load in the humerus enable the cyst to grow
unrecognized until the structural characteristics of the
bone are limited and subsequent a pathological fracture
occurs. Since the long bone of the lower extremity with-
stand a considerable weight load pain as a first symptome
is recognized.long before a mechanical threat happens.
The cyst index, which was increased in the humerus com-
pared to the femur support this hypothesis too.
After a course of three consecutive intralesional injec-
tions of methylprednisolon acetat the failure rate was
36,6 % in our patients. In comparable trials the rate is
between 32 and 24 % [3, 17, 18]. In a previous study
from our institution including 71 patients with SBC the
failure rate was similar ~30 % [16]. Although Scaglietti
et al. [9] have reported doses up to 240 mg, we are not
aware of any dose–response curve that suggests higher
doses are more effective. The study by Wright et al. [13]
Table 3 The influence of different clinical factors on the healing rates
Location Conservative Steroids IN IN + steroids Curettage + bone
(n = 22) (n = 41) (n = 8) (n = 54) Graft (n = 8)
Humerus 8 (4) 20 (8) 3 (1) 27 (4) 1
Femur 3 (1) 13 (3) 5 (3) 26 (8) 2
Tibia Tibia 1 2
Fibula 3 (1) 2 (1)
Radius 1 1
Calcaneus 6 1 1
Os pubis 1 1 (1) 1
Os ilium 1 1
Fig. 1 Kaplan-Meier analysis of the different treatment groups after initial treatment
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revealed that steroids are the only evidence based
therapy.
To achieve higher rates of success with one single
intervention, some authors advocated injection of bone
marrow, together with multiple perforations of the cyst
wall to re-establish the continuity between the cavity of
the cyst and the adjacent normal marrow [8, 13]. This
strategy makes it difficult to separate the effects of
mechanical disruption from those produced by the
osteogenic capacity of bone marrow injected into the
cyst. In another report of 79 patients where steroid in-
jections were compared with injection of bone marrow,
no advantage of one or the other method could be
shown [19]. Referring to the only randomized prospect-
ive clinical trial steroid injection still showed a signifi-
cantly better outcome than bone marrow [13].
The intramedullary nailing of long bones is not a new
concept [20]. Some studies reported and success rates
between 75 and 100 % [21, 22]. Using this technique has
the advantage of a minimal invasive procedure, immedi-
ately stability and continuous decompression. Since
there is no further cortical impairment (as in e.g. curet-
tage), hospital stay and return to normal activity are
positively affected. Moreover, this technique can easily
be combined with other procedures during one inter-
vention, such as injection of steroids. The success rates
in the presented study of 50 %, resp. 79.6 % are consist-
ent with those reported in the literature. The relatively
high failure rate of 50 % can be explained with the
growth of the children. The nails did not bridge the cyst
in 3 of 4 cases during the healing course, and an ex-
change of the intramedullary nails was necessary. This
hypothesis is supported by the proportional late conse-
quential operations. We did not find significant differ-
ences of the treatment according to the location (upper
vs. lower extremity). In our experience the combination
of intramedullary nailing and a course of steroid injec-
tion showed the best clinical result and is our preferred
treatment option in the case of non obliteration of the
cyst or in weight bearing long-bones.
Curettage and disruption of the cyst lining combined
with bone grafting has been considered as the gold
standard for many years [2]. This procedure provides
enough osteogenic stimulus to enhance healing [16, 23].
Nevertheless, there is a need for less invasive strategy,
considering the benign and self-limited nature of the le-
sion [24]. In a small study percutaneous curettage alone
showed to be superior to intralesional injections and
thus this approach was favored by the authors [25].
Studies reporting the efficacy of bone substitutes are
limited [17]. Only few clinical studies are found in the
literature. The recovery rates vary between 66 % up to
100 %. But most of these studies have a lack of follow-
up >12 month after diagnosis [6]. In our study, patients
initially treated by curettage with a combined bone graft-
ing (group IV) no recurrence was observed. We assume
that these good results can be explained on the one
hand by the location of the SBC and the mechanical
stress and on the other hand to the age of the patient
(>11 years).
In this study we were able to offer long-term clinical
outcome for conservative and surgical treatment of SBC.
Our results confirm the satisfactory overall long-term
outcome. Focusing on short-and mid-term surveillance a
substantial rate of recurrence for all different treatment
strategies could be detected. Long-term follow up of
more than 24 months is rarely conveyed in many other
studies. We not only focused on the radiographic ap-
pearance, but also included, pain, function and re-
fracture rates. Considering the assumed long-term suc-
cess of SBC therapy, invasive strategies have to be car-
ried out as cautious as possible. In one study with a
7 year follow-up the residual cyst persist into early adult-
hood, but no further fractures were detected even when
the healing was graded III or IV [26].
Conclusion
We believe that the invasiveness of the procedure must
be contrasted by the need for repeated treatment (e.g.
steroids). These factors must be balanced against risk of
fracture and probability of success rate. Small, non
symptomatic and latent SBC (particular in the calcaneus
or the pelvic bones) can be observed and if necessary,
therapy with injection of steroids can be started. Since
we did not have any fractures in our group III we rec-
ommend internal fixation and the injection of steroids in
long bones with a mechanical load to reduce fracture
rate and to expedite the recovery of the child. In the
upper extremity the cyst volume, the cyst index and the
activity level should be considered when making a rec-
ommendation. The treatment options of conservative
versus steroids injection versus fracture fixation and ste-
roids should be discussed with the patient and the
parents.
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